Matthew Walter

26PUBLICATIONS

186CO-AUTHORS

Liquid biopsiesRegenerative medicine (incl. stem cells)Molecular targetsHaematological tumoursPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (26)

Sort by Publication Date:

|Jun 04, 2026

Long-read cDNA sequencing reveals novel isoforms and spliceosome-mutant-enriched transcripts in AML and MDS.

|May 06, 2026

U2af1S34F and U2af1Q157R myeloid neoplasm-associated hotspot mutations induce distinct hematopoietic phenotypes in mice.

|Apr 09, 2026

Nonsense-Mediated RNA Decay is a Targetable Vulnerability in Splicing Factor Mutant Myeloid Neoplasms by Enhancing R-loop Accumulation and DNA Damage.

Claudia Cabrera Pastrana, Sridhar Nonavinkere Srivatsan, Michael O Alberti

|Feb 16, 2026

Modeling the evolutionary dynamics of clonal hematopoiesis.

Sadegh Marzban, Thomas Stiehl, Zhuoer Xie

|Nov 24, 2025

Sensitivity to ATR-CHK1 pathway inhibition in AML/MDS is enhanced by SRSF2 mutations and reduced by RUNX1 loss.

Samuli Eldfors, Sumit Rai, Vineet Sharma

|Jul 15, 2025

Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy.

Jie Liu, Duc Tran, Liying Xue

Pageof 5

Frequent Collaborators

6 joint publications

Christopher Miller

6 joint publications

Timothy A Graubert

5 joint publications

Sridhar Nonavinkere Srivatsan

3 joint publications

Claudia Cabrera Pastrana

Jie Liu

Benjamin L Ebert

Daniel C Link

Michael O Alberti

Yin Cao

Kelly L Bolton

Frequent Collaborators

6 joint publications

Christopher Miller

6 joint publications

Timothy A Graubert

5 joint publications

Sridhar Nonavinkere Srivatsan

3 joint publications

Claudia Cabrera Pastrana